Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients

American Journal of Kidney Diseases

Volumn 45, Issue 4, 2005, Pages 702-707

  Mallamaci, Francesca ^b   Bonanno, Grazia ^b   Seminara, Giuseppe ^b   Rapisarda, Francesco ^b   Fatuzzo, Pasquale ^b   Candela, Vincenzo ^b   Scudo, Paolo ^b   Spoto, Belinda ^b   Testa, Alessandra ^b   Tripepi, Giovanni ^b   Tech, Stat ^b   Zoccali, Carmine ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b NONE

Author keywords

Arteriovenous (AV) fistula; hemodialysis (HD); homocysteine; methylenetetrahydrofolate reductase (MTHFR) genotype; vascular access (VA) thrombosis

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREDICTION; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; STATISTICAL MODEL; SURVIVAL; THROMBOSIS; VASCULAR ACCESS;

EID: 20144388582     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.01.004     Document Type: Article

References (28)

1. J.D. Woods, F.K. Port The impact of vascular access for haemodialysis on patient morbidity and mortality Nephrol Dial Transplant 12 1997 657 659
2. D.N. Churchill, D.W. Taylor, R.J. Cook Canadian Hemodialysis Morbidity Study Am J Kidney Dis 19 1992 214 234
3. D.W. Windus, M.D. Jendrisak, J.A. Delmez Prosthetic fistula survival and complications in hemodialysis patients Effects of diabetes and age Am J Kidney Dis 19 1992 448 452
4. K. Culp, M. Flanigan, L. Taylor, M. Rothstein Vascular access thrombosis in new hemodialysis patients Am J Kidney Dis 26 1995 341 346
5. P.E. Miller, D. Carlton, M.H. Deierhoi, D.T. Redden, M. Allon Natural history of arteriovenous grafts in hemodialysis patients Am J Kidney Dis 36 2000 68 74
6. P. Goldwasser, M.A. Michel, J. Collier Prealbumin and lipoprotein(a) in hemodialysis Relationships with patient and vascular access survival Am J Kidney Dis 22 1993 215 225
7. P. Brunet, M.F. Aillaud, M. San Marco Antiphospholipids in hemodialysis patients Relationship between lupus anticoagulant and thrombosis Kidney Int 48 1995 794 800
8. R.P. Wuthrich Factor V Leiden mutation Potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis Curr Opin Nephrol Hypertens 10 2001 409 414
9. F. Mallamaci, C. Zoccali, G. Tripepi Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients Kidney Int 61 2002 609 614
10. A. Moustapha, A. Naso, M. Nahlawi Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease Circulation 97 1998 138 141
11. E.M. Wrone, J.L. Zehnder, J.M. Hornberger, L.M. McCann, N.S. Coplon, S.P. Fortmann An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease Kidney Int 60 2001 1106 1113
12. D. Shemin, K.L. Lapane, L. Bausserman Plasma total homocysteine and hemodialysis access thrombosis A prospective study J Am Soc Nephrol 10 1999 1095 1099
13. B.J. Manns, E.D. Burgess, H.G. Parsons, J.P. Schaefer, M.E. Hyndman, N.W. Scott-Douglas Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients Kidney Int 55 1999 315 320
14. R.G. Bowden, F.B. Wyatt, R. Wilson Homocysteine and vascular access thrombosis in end-stage renal disease patients A retrospective study J Nephrol 15 2002 666 670
15. S. Sirrs, L. Duncan, O. Djurdjev Homocyst(e)ine and vascular access complications in haemodialysis patients Insights into a complex metabolic relationship Nephrol Dial Transplant 14 1999 738 743
16. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, P.E. Barre Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease J Am Soc Nephrol 7 1996 728 736
17. S.A. Miller, D.D. Dykes, H.F. Polesky Salting out procedure for extracting DNA from human nucleated cells Nucl Acids Res 16 1998 1215
18. P. Frosst, H.J. Blom, R. Milos A candidate genetic risk factor for vascular disease A common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
19. H. Kimura, F. Gejyo, S. Suzuki, T. Takeda, R. Miyazaki, H. Yoshida A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients Am J Kidney Dis 36 2000 925 933
20. P.Y. Fan, S.J. Schwab Vascular access Concepts for the 1990s J Am Soc Nephrol 3 1992 1 11
21. H.I. Feldman, S. Kobrin, A. Wasserstein Hemodialysis vascular access morbidity J Am Soc Nephrol 7 1996 523 535
22. R. Munda, M.R. First, J.W. Alexander, C.C. Linnemann Jr., J.P. Fidler, D. Kittur Polytetrafluoroethylene graft survival in hemodialysis JAMA 249 1983 219 222
23. C.J. Boushey, S.A. Beresford, G.S. Omenn, A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
24. M. Kikura, T. Takada, S. Sato Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS) Thromb Haemost 91 2004 725 732
25. E.M. Wrone, J.M. Hornberger, J.L. Zehnder, L.M. McCann, N.S. Coplon, S.P. Fortmann Randomized trial of folic acid for prevention of cardiovascular events in end stage renal disease J Am Soc Nephrol 15 2004 420 426
26. M. Klerk, P. Verhoef, R. Clarke, H.J. Blom, F.J. Kok, E.G. Schouten MTHFR Studies Collaboration Group MTHFR 677C→T polymorphism and risk of coronary heart disease A meta-analysis JAMA 288 2002 2023 2031
27. M. Fodinger, H. Buchmayer, G. Heinz Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients Am J Kidney Dis 38 2001 77 84
28. M. Fukasawa, K. Matsushita, M. Kamiyama The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients Am J Kidney Dis 41 2003 637 642